Ron DePinho, Professor and Past President of MD Anderson Cancer Center, shared a post on LinkedIn
“The news of Ben Sasse’s stage-4 pancreatic cancer is a stark reminder of both how far cancer science has come—and how far we still must go.
Pancreatic cancer remains one of the deadliest malignancies, largely because it is detected too late and lacks effective interception strategies. Breakthroughs in immunotherapy and precision medicine show what is possible when research is sustained. But progress is fragile. Continued, robust investment in cancer research is not optional—it is lifesaving.
Lives truly are on the line.”
More posts featuring Ron DePinho.